Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
17227 | 610 | 29.7 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
525 | 3 | TOXOPLASMA GONDII//NEOSPORA CANINUM//TOXOPLASMOSIS | 20385 |
646 | 2 | TOXOPLASMA GONDII//NEOSPORA CANINUM//TOXOPLASMOSIS | 13622 |
17227 | 1 | ATOVAQUONE//TOXOPLASMA ENCEPHALITIS//TOXOPLASMIC ENCEPHALITIS | 610 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ATOVAQUONE | authKW | 343964 | 5% | 21% | 32 |
2 | TOXOPLASMA ENCEPHALITIS | authKW | 225246 | 1% | 50% | 9 |
3 | TOXOPLASMIC ENCEPHALITIS | authKW | 196716 | 2% | 30% | 13 |
4 | CENTRAL NERVOUS SYSTEM TOXOPLASMOSIS | authKW | 112626 | 0% | 75% | 3 |
5 | CRB TOXOPLASMA | address | 100113 | 0% | 100% | 2 |
6 | MALARIA TOXOPLASMOSIS BIOL MAT | address | 100113 | 0% | 100% | 2 |
7 | WITHDRAWAL OF PROPHYLAXIS | authKW | 100113 | 0% | 100% | 2 |
8 | TOXOPLASMOSIS | authKW | 87187 | 8% | 4% | 49 |
9 | CEREBRAL TOXOPLASMOSIS | authKW | 75692 | 2% | 14% | 11 |
10 | BRAIN TOXOPLASMOSIS | authKW | 75082 | 0% | 50% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Infectious Diseases | 7409 | 33% | 0% | 201 |
2 | Microbiology | 3396 | 32% | 0% | 193 |
3 | Parasitiology | 1232 | 9% | 0% | 54 |
4 | Medicine, General & Internal | 975 | 20% | 0% | 119 |
5 | Immunology | 951 | 20% | 0% | 123 |
6 | Pharmacology & Pharmacy | 730 | 22% | 0% | 134 |
7 | Tropical Medicine | 416 | 4% | 0% | 25 |
8 | Virology | 192 | 5% | 0% | 29 |
9 | Public, Environmental & Occupational Health | 19 | 4% | 0% | 23 |
10 | Primary Health Care | 19 | 1% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CRB TOXOPLASMA | 100113 | 0% | 100% | 2 |
2 | MALARIA TOXOPLASMOSIS BIOL MAT | 100113 | 0% | 100% | 2 |
3 | ADULT ADOLESCENT SPE UM HIV DIS GRP | 50057 | 0% | 100% | 1 |
4 | AIDS CLEARINGHOUSE | 50057 | 0% | 100% | 1 |
5 | AMAZONIAN ACT PRINCIPLES | 50057 | 0% | 100% | 1 |
6 | ARTHUR ASHE CHAIR PEDIAT AIDS | 50057 | 0% | 100% | 1 |
7 | AUDIE MUPHY VET ADM HOSP HLTH SCI | 50057 | 0% | 100% | 1 |
8 | BIOL PHYSIOL IMMUNOL PROTOZOANS HUMAN INTER | 50057 | 0% | 100% | 1 |
9 | BIOS BIOMATERIAUX INFLAMMAT SITE OSSEUX EA 4691 | 50057 | 0% | 100% | 1 |
10 | CERRAHPASHA MED | 50057 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 11574 | 12% | 0% | 74 |
2 | CLINICAL INFECTIOUS DISEASES | 5601 | 6% | 0% | 38 |
3 | AIDS | 3900 | 4% | 0% | 26 |
4 | EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 3162 | 3% | 0% | 20 |
5 | EXPERIMENTAL PARASITOLOGY | 2246 | 2% | 0% | 15 |
6 | PATHOGENS AND GLOBAL HEALTH | 1626 | 0% | 1% | 3 |
7 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 1393 | 1% | 0% | 7 |
8 | INTERNATIONAL JOURNAL OF STD & AIDS | 1215 | 2% | 0% | 10 |
9 | PARASITE-JOURNAL DE LA SOCIETE FRANCAISE DE PARASITOLOGIE | 1158 | 0% | 1% | 3 |
10 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1133 | 3% | 0% | 17 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ATOVAQUONE | 343964 | 5% | 21% | 32 | Search ATOVAQUONE | Search ATOVAQUONE |
2 | TOXOPLASMA ENCEPHALITIS | 225246 | 1% | 50% | 9 | Search TOXOPLASMA+ENCEPHALITIS | Search TOXOPLASMA+ENCEPHALITIS |
3 | TOXOPLASMIC ENCEPHALITIS | 196716 | 2% | 30% | 13 | Search TOXOPLASMIC+ENCEPHALITIS | Search TOXOPLASMIC+ENCEPHALITIS |
4 | CENTRAL NERVOUS SYSTEM TOXOPLASMOSIS | 112626 | 0% | 75% | 3 | Search CENTRAL+NERVOUS+SYSTEM+TOXOPLASMOSIS | Search CENTRAL+NERVOUS+SYSTEM+TOXOPLASMOSIS |
5 | WITHDRAWAL OF PROPHYLAXIS | 100113 | 0% | 100% | 2 | Search WITHDRAWAL+OF+PROPHYLAXIS | Search WITHDRAWAL+OF+PROPHYLAXIS |
6 | TOXOPLASMOSIS | 87187 | 8% | 4% | 49 | Search TOXOPLASMOSIS | Search TOXOPLASMOSIS |
7 | CEREBRAL TOXOPLASMOSIS | 75692 | 2% | 14% | 11 | Search CEREBRAL+TOXOPLASMOSIS | Search CEREBRAL+TOXOPLASMOSIS |
8 | BRAIN TOXOPLASMOSIS | 75082 | 0% | 50% | 3 | Search BRAIN+TOXOPLASMOSIS | Search BRAIN+TOXOPLASMOSIS |
9 | PYRIMETHAMINE | 71730 | 3% | 8% | 18 | Search PYRIMETHAMINE | Search PYRIMETHAMINE |
10 | DISCONTINUATION OF PROPHYLAXIS | 66741 | 0% | 67% | 2 | Search DISCONTINUATION+OF+PROPHYLAXIS | Search DISCONTINUATION+OF+PROPHYLAXIS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | NEVILLE, AJ , ZACH, SJ , WANG, XF , LARSON, JJ , JUDGE, AK , DAVIS, LA , VENNERSTROM, JL , DAVIS, PH , (2015) CLINICALLY AVAILABLE MEDICINES DEMONSTRATING ANTI-TOXOPLASMA ACTIVITY.ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. VOL. 59. ISSUE 12. P. 7161 -7169 | 42 | 45% | 2 |
2 | CONNOLLY, MP , GOODWIN, E , SCHEY, C , ZUMMO, J , (2017) TOXOPLASMIC ENCEPHALITIS RELAPSE RATES WITH PYRIMETHAMINE-BASED THERAPY: SYSTEMATIC REVIEW AND META-ANALYSIS.PATHOGENS AND GLOBAL HEALTH. VOL. 111. ISSUE 1. P. 31 -44 | 29 | 54% | 0 |
3 | FUNG, HB , KIRSCHENBAUM, HL , (1996) TREATMENT REGIMENS FOR PATIENTS WITH TOXOPLASMIC ENCEPHALITIS.CLINICAL THERAPEUTICS. VOL. 18. ISSUE 6. P. 1037-1056 | 38 | 69% | 34 |
4 | GOSWAMI, RP , GOSWAMI, RP , RAHMAN, M , RAY, Y , TRIPATHI, SK , (2015) ALTERNATIVE TREATMENT APPROACH TO CEREBRAL TOXOPLASMOSIS IN HIV/AIDS: EXPERIENCE FROM A RESOURCE-POOR SETTING.INTERNATIONAL JOURNAL OF STD & AIDS. VOL. 26. ISSUE 12. P. 864 -869 | 15 | 94% | 0 |
5 | STGEORGIEV, V , (1993) OPPORTUNISTIC NOSOCOMIAL INFECTIONS - TREATMENT AND DEVELOPMENTAL THERAPEUTICS - TOXOPLASMOSIS.MEDICINAL RESEARCH REVIEWS. VOL. 13. ISSUE 5. P. 529-568 | 54 | 47% | 5 |
6 | COSTINIUK, CT , FERGUSSON, DA , DOUCETTE, S , ANGEL, JB , (2011) DISCONTINUATION OF PNEUMOCYSTIS JIROVECII PNEUMONIA PROPHYLAXIS WITH CD4 COUNT <200 CELLS/MU L AND VIROLOGIC SUPPRESSION: A SYSTEMATIC REVIEW.PLOS ONE. VOL. 6. ISSUE 12. P. - | 21 | 64% | 9 |
7 | SCHOLER, N , KRAUSE, K , KAYSER, O , MULLER, RH , BORNER, K , HAHN, H , LIESENFELD, O , (2001) ATOVAQUONE NANOSUSPENSIONS SHOW EXCELLENT THERAPEUTIC EFFECT IN A NEW MURINE MODEL OF REACTIVATED TOXOPLASMOSIS.ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. VOL. 45. ISSUE 6. P. 1771-1779 | 25 | 66% | 47 |
8 | HERNANDEZ, AV , THOTA, P , PELLEGRINO, D , PASUPULETI, V , BENITES-ZAPATA, VA , DESHPANDE, A , DE OLIVEIRA, ACP , VIDAL, JE , (2017) A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE RELATIVE EFFICACY AND SAFETY OF TREATMENT REGIMENS FOR HIV-ASSOCIATED CEREBRAL TOXOPLASMOSIS: IS TRIMETHOPRIM-SULFAMETHOXAZOLE A REAL OPTION?.HIV MEDICINE. VOL. 18. ISSUE 2. P. 115 -124 | 13 | 54% | 1 |
9 | MIRO, JM , LOPEZ, JC , PODZAMCZER, D , PENA, JM , ALBERDI, JC , MARTINEZ, E , DOMINGO, P , COSIN, J , CLARAMONTE, X , ARRIBAS, JR , ET AL (2006) DISCONTINUATION OF PRIMARY AND SECONDARY TOXOPLASMA GONDII PROPHYLAXIS IS SAFE IN HIV-INFECTED PATIENTS AFTER IMMUNOLOGICAL RESTORATION WITH HIGHLY ACTIVE ANTIRETROVIRAL THERAPY: RESULTS OF AN OPEN, RANDOMIZED, MULTICENTER CLINICAL TRIAL.CLINICAL INFECTIOUS DISEASES. VOL. 43. ISSUE 1. P. 79 -89 | 22 | 65% | 13 |
10 | CATALANO-PONS, C , BARGY, S , SCHLECHT, D , TABONE, MD , DESCHENES, G , BENSMAN, A , ULINSKI, T , (2004) SULFADIAZINE-INDUCED NEPHROLITHIASIS IN CHILDREN.PEDIATRIC NEPHROLOGY. VOL. 19. ISSUE 8. P. 928-931 | 15 | 94% | 8 |
Classes with closest relation at Level 1 |